|88.61||-5.58||-5.92%||Vol 306.92K||1Y Perf 270.78%|
|Sep 24th, 2021 16:00 DELAYED|
|- -||- -%|
|Target Price||128.64||Analyst Rating||Strong Buy 1.22|
|Potential %||45.18||Finscreener Ranking||★★★★+ 55.11|
|Insiders Trans % 3/6/12 mo.||-100/-100/-89||Value Ranking||★★★★ 57.09|
|Insiders Value % 3/6/12 mo.||-100/-100/-39||Growth Ranking||★★★★ 61.01|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-30||Income Ranking||— -|
|Price Range Ratio 52W %||77.64||Earnings Rating||Strong Buy|
|Market Cap||4.36B||Earnings Date||4th Nov 2021|
Today's Price Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||4th Nov 2021|
|Estimated EPS Next Report||3.90|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||243.96K|
|Avg. Monthly Volume||358.62K|
|Avg. Quarterly Volume||456.58K|
Arvinas Inc. (NASDAQ: ARVN) stock closed at 88.61 per share at the end of the most recent trading day (a -5.92% change compared to the prior day closing price) with a volume of 309.97K shares and market capitalization of 4.36B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 133 people. Arvinas Inc. CEO is John Houston.
The one-year performance of Arvinas Inc. stock is 270.78%, while year-to-date (YTD) performance is 4.33%. ARVN stock has a five-year performance of %. Its 52-week range is between 19.68 and 108.46, which gives ARVN stock a 52-week price range ratio of 77.64%
Arvinas Inc. currently has a PE ratio of -26.30, a price-to-book (PB) ratio of 8.71, a price-to-sale (PS) ratio of 232.53, a price to cashflow ratio of 25.60, a PEG ratio of 2.32, a ROA of -36.09%, a ROC of -41.90% and a ROE of -41.91%. The company’s profit margin is -%, its EBITDA margin is -757.30%, and its revenue ttm is $20.90 Million , which makes it $0.40 revenue per share.
Of the last four earnings reports from Arvinas Inc., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $3.90 for the next earnings report. Arvinas Inc.’s next earnings report date is 04th Nov 2021.
The consensus rating of Wall Street analysts for Arvinas Inc. is Strong Buy (1.22), with a target price of $128.64, which is +45.18% compared to the current price. The earnings rating for Arvinas Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Arvinas Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Arvinas Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 17.35, ATR14 : 4.13, CCI20 : -23.35, Chaikin Money Flow : 0.21, MACD : 1.21, Money Flow Index : 62.53, ROC : -3.56, RSI : 45.20, STOCH (14,3) : 23.15, STOCH RSI : 0.00, UO : 44.87, Williams %R : -76.85), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Arvinas Inc. in the last 12-months were: Bradley Margus (Sold 29 940 shares of value $2 545 168 ), Edward Kennedy (Buy at a value of $199 909), Ian Taylor (Option Excercise at a value of $823 296), Ian Taylor (Sold 45 894 shares of value $3 485 300 ), John G. Houston (Option Excercise at a value of $1 538 752), John G. Houston (Sold 98 037 shares of value $8 587 518 ), John Houston (Option Excercise at a value of $728 960), John Houston (Sold 44 000 shares of value $3 466 601 ), Liam Ratcliffe (Buy at a value of $9 999 990), Ronald Peck (Option Excercise at a value of $531 600), Ronald Peck (Sold 21 363 shares of value $1 670 391 ), Sean A. Cassidy (Option Excercise at a value of $733 744), Sean A. Cassidy (Sold 44 180 shares of value $3 464 123 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
This could take some time, please wait.